Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model.
J Control Release
; 341: 341-350, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34848243
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Aptamers, Nucleotide
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Australia